{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:19:56Z","timestamp":1773116396257,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1124\/jpet.116.233544","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T04:06:16Z","timestamp":1465445176000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of (+)- and (\u2212)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice"],"prefix":"10.1016","volume":"358","author":[{"given":"Guro S\u00f8e","family":"Eriksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannike M\u00f8rch","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Boix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Skov-Skov","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vigdis","family":"Vindenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rg","family":"M\u00f8rland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.233544_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.113.212035","article-title":"A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice","volume":"349","author":"Bogen","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2010.00298.x","article-title":"Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice","volume":"18","author":"Boix","year":"2013","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.116.233544_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(97)00710-2","article-title":"3-Methoxynaltrexone, a selective heroin\/morphine-6beta-glucuronide antagonist","volume":"412","author":"Brown","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.116.233544_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pbb.2014.03.018","article-title":"3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice","volume":"122","author":"Eriksen","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.233544_bib6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bcp.2011.03.001","article-title":"Distinct pharmacological properties of morphine metabolites at G(i)-protein and \u03b2-arrestin signaling pathways activated by the human \u03bc-opioid receptor","volume":"81","author":"Fr\u00f6lich","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.233544_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S1461145714000169","article-title":"Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin","volume":"17","author":"Gott\u00e5s","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.116.233544_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(25)11333-5","article-title":"Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation","volume":"260","author":"Hubner","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib9","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.116.233544_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.116.233544_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1124\/jpet.116.233544_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/jm00202a018","article-title":"Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone","volume":"21","author":"Iijima","year":"1978","journal-title":"J Med Chem"},{"issue":"Suppl 1","key":"10.1124\/jpet.116.233544_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding studies that heroin acts through its metabolites","volume":"33","author":"Inturrisi","year":"1983","journal-title":"Life Sci"},{"key":"10.1124\/jpet.116.233544_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3565(25)22000-6","article-title":"Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity","volume":"227","author":"Kalivas","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib15","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.0811586106","article-title":"Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions","volume":"106","author":"Pan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.233544_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","article-title":"Incentive-sensitization and addiction","volume":"96","author":"Robinson","year":"2001","journal-title":"Addiction"},{"key":"10.1124\/jpet.116.233544_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","article-title":"Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature","volume":"1","author":"Rook","year":"2006","journal-title":"Curr Clin Pharmacol"},{"key":"10.1124\/jpet.116.233544_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(96)12976-1","article-title":"Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia","volume":"216","author":"Rossi","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.116.233544_bib20","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.233544_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/5706","article-title":"Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1","volume":"2","author":"Schuller","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.116.233544_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopsych.2012.12.019","article-title":"Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving","volume":"73","author":"Theberge","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.233544_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(25)32685-6","article-title":"Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice","volume":"218","author":"Umans","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3565(25)31172-9","article-title":"Intravenous self-administration of drugs in rats","volume":"204","author":"van Ree","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233544_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pbb.2008.01.012","article-title":"Different time schedules affect conditioned place preference after morphine and morphine-6-glucuronide administration","volume":"89","author":"Vindenes","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.233544_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2009.03.013","article-title":"Interactions between morphine and the morphine-glucuronides measured by conditioned place preference and locomotor activity","volume":"93","author":"Vindenes","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.233544_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(99)00633-0","article-title":"Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone","volume":"383","author":"Walker","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233544_bib28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.233544_bib29","first-page":"25","article-title":"Metabolism of heroin and its pharmacologic implications","volume":"17","author":"Way","year":"1965","journal-title":"Bull Narc"},{"key":"10.1124\/jpet.116.233544_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1124\/jpet.116.233544_bib31","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/j.1460-9568.2006.05144.x","article-title":"dextro-Naloxone or levo-naloxone reverses the attenuation of morphine antinociception induced by lipopolysaccharide in the mouse spinal cord via a non-opioid mechanism","volume":"24","author":"Wu","year":"2006","journal-title":"Eur J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.233544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:47:06Z","timestamp":1739994426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0022356524193743"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.233544","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of (+)- and (\u2212)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.233544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}